Showing results (201-210 of 212) with videos related to
Sort By:
Pageof 22
Nature Communications|June 9, 2017
Loss of Asxl2 leads to myeloid malignancies in miceJianping Li, Fuhong He, Peng Zhang, et al.JCI Insight|October 8, 2021
p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemiaNa Man, Gloria Mas, Daniel L Karl, et al.Nature Medicine|January 14, 2021
Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trialMichael J Fisher, Chie-Schin Shih, Steven D Rhodes, et al.American Journal of Medical Genetics. Part A|September 19, 2009
Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic optionsFlorent Elefteriou, Mateusz Kolanczyk, Aaron Schindeler, et al.American Journal of Medical Genetics. Part A|January 21, 2014
CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapiesBrigitte C Widemann, Maria T Acosta, Sylvia Ammoun, et al.Nature Medicine|January 6, 2025
Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trialAndrea M Gross, Geraldine O'Sullivan Coyne, Eva Dombi, et al.Cancer Cell|June 13, 2018
CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal HematopoiesisSarah M Greenblatt, Na Man, Pierre-Jacques Hamard, et al.Cell Stem Cell|February 15, 2025
PSPC1 exerts an oncogenic role in AML by regulating a leukemic transcription program in cooperation with PU.1Juyeong Hong, Pinpin Sui, Ying Li, et al.Nature Communications|April 26, 2017
Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cellsFeng Pan, Thomas S Wingo, Zhigang Zhao, et al.Proceedings of the National Academy of Sciences of the United States of America|July 3, 2013
TET1 plays an essential oncogenic role in MLL-rearranged leukemiaHao Huang, Xi Jiang, Zejuan Li, et al.Pageof 22